MGX-0024

MGX-0024 is a patented, all-natural antiviral compound developed by Mangoceuticals, Inc. in collaboration with IntraMont Technologies for veterinary and agricultural applications. Specifically formulated for poultry, the agent is administered via drinking water to prevent and treat a range of respiratory diseases, including highly pathogenic avian influenza (HPAI) H5N1, Newcastle Disease, Infectious Bronchitis (IBH), Infectious Laryngotracheitis (ILT), and Chronic Respiratory Disease (CRD). Field trials and controlled BSL-3 studies have demonstrated significant reductions in mortality among infected broiler chickens. While the specific active ingredients and molecular targets are proprietary, the developer emphasizes the compound's safety and non-toxic profile for use in large-scale poultry production.

Other names

MGX-0024MGX0024MGX 0024